Beneficial effect of treatment with cyclosporin A in a case of refractory antisynthetase syndrome

Rheumatology International

Volumn 27, Issue 8, 2007, Pages 775-780

  Jankowska, Magdalena ^a   Butto, Barbara ^a   Dębska Ślizień, Alicja ^a   Rutkowski, Bolesław ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHYLPREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; ANAMNESIS; ANTISYNTHETASE SYNDROME; ARTICLE; BRONCHOSCOPY; CASE REPORT; DISEASE COURSE; DRUG EFFICACY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HOSPITALIZATION; HUMAN; LABORATORY TEST; LUNG DISEASE; LUNG FUNCTION TEST; PATHOLOGIC FRACTURE; PHYSICAL EXAMINATION; PNEUMONIA; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RHEUMATOID ARTHRITIS; THORAX RADIOGRAPHY; TOXOPLASMOSIS; VITAL SIGN;

EID: 34248222249     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-006-0289-y     Document Type: Article

References (35)

1. Oddis CV, Rider LG, Reed AM, Ruperto N, Brunner HI, Koneru B, Feldman BM, Giannini EH, Miller FW (2005) International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum 9:2607-2615
2. Choy EHS, Isenberg DA (2002) Treatment of dermatomyositis and polymyositis. Rheumatology 41:7-13
3. Fathi M, Dastmalchi M, Rasmussen E, Lundberg IE, Torling G (2004) Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 3:297-301
4. Kalenian M, Zweiman B (1997) Inflammatory myopathy, bronchiolitis obliterans/organizing pneumonia, and anti-Jo-1 antibodies - an interesting association. Clin Diagn Lab Immunol 2:236-240
5. Schmidt WA, Wetzel W, Friedlander R, Lange R, Sorensen HF, Lichey HJ, Genth E, Mierau R, Gromnica-Ihle E (2000) Clinical and serological aspects of patients with anti-Jo-1 antibodies - an evolving spectrum of disease manifestations. Clin Rheumatol 5:371-377
6. Gabbay E, Tarala R, Will R, Carroll G, Adler B, Cameron D, Lake FR (1997) Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 156:528-535
7. Ponyi A, Constantin T, Danko K (2004) Antiphospholipid and antisynthetase syndrome in a patient with polymyositis-rheumatoid arthritis overlap. Clin Rheumatol 4:371-372
8. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 8:403-407
9. Jorizzo JL (2002) Dermatomyositis: practical aspects. Arch Dermatol 38:114-116
10. Akira M, Hara H, Sakatani M (1999) Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients. Radiology 2:333-338
11. Oddis CV (2000) Current approach to the treatment of polymyositis and dermatomyositis. Curr Opin Rheumatol 12:492-497
12. Mosca M, Neri R, Pasero G, Bombardieri S (2000) Treatment of the idiopathic inflammatory myopathies: a retrospective analysis of 63 Caucasian patients longitudinally followed at a single center. Clin Exp Rheumatol 4:451-456
13. Marie I, Hachulla E, Cherin P, Dominique S, Hatron PY, Hellot MF, Devulder B, Herson S, Levesque H, Courtois H (2002) Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 6:614-622
14. Aoun NY, Velez E, Aggarwal A, Hayes GB, Kenney LA (2004) Fatal acute interstitial pneumonitis complicating polymyositis in a 41-year-old man. Respir Care 12:1515-1521
15. Schinohara T, Hidaka T, Matsuki Y, Ishizuka T, Takamizawa M, Kawakami M, Kikuma H, Suzuki K, Nakamura H (1997) Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide pulse therapy. Intern Med 7:519-523
16. Tomsik M, Sifrer F (2000) Acute respiratory distress syndrome in a polymyositis patient with anti-Jo1 antibody. Wien Klin Wochenschr 25:728-731
17. Yoshida T, Koga H, Saitoh F, Sakamoto M, Harada M, Yoshida H, Sakisaka S, Sata M (1999) Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis. Intern Med 9:733-738
18. Baer AN (2006) Advances in the therapy of idiopathic inflammatory myopathies. Curr Opin Rheumatol 3:236-241
19. Lambotte O, Kotb R, Maigne G, Blanc FX, Goujard C, Delfraissy JF (2005) Efficacy of rituximab in refractory polymyositis. J Rheumatol 7:1369-1370
20. Lange U, Piegsa M, Muller-Ladner U, Strunk J (2006) Anti-Jo-1 antibody positive polymyositis-successful therapy with leflunomide. Autoimmunity 3:261-264
21. Danieli MG, Malcangi G, Palmieri C, Salvi A, Piani M, Danieli G (2002) Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/ dermatomyositis. Ann Rheum Dis 61:37-34
22. Mitsunaka H, Tokuda M, Hiraishi T, Dobashi H, Takahara J (2000) Combined use of cyclosporin and methotrexate in refractory polymyositis. Scand J Rheumatol 29:192-194
23. Qushmaq KA, Chalmers A, Esdaile JM (2000) Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review. J Rheumatol 27:2855-2859
24. Tellus MM, Buchanan RR (1997) Effective treatment of anti-Jo1 antibody positive polymyositis with cyclosporin. Br J Rheumatol 12:1187-1188
25. Tanaka F, Origuchi T, Migita K, Tominaga M, Kawakami A, Kawabe Y, Eguchi K (2000) Successful combined therapy of cyclophosphamide and cyclosporin for acute exacerbated interstitial pneumonia associated with dermatomyositis. Intern Med 5:428-430
26. Kameda H, Nagasawa H, Ogawa H, Sekiguchi N, Takei H, Tokuhira M, Amano K, Takeuchi T (2005) Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol 9:1719-1726
27. Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, Kita Y, Kawai M, Saito Y, Iwamoto I (1999) Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporin. J Rheumatol 7:1527-1533
28. Shimojima Y, Ishii W, Kato T, Hoshi K, Matsuda M, Hashimoto T, Tanaka Y, Ikeda S (2003) Intractable skin necrosis and interstitial pneumonia in amyopathic dermatomyositis, successfully treated with cyclosporin A. Intern Med 12:1253-1258
29. Dawson JK, Abernethy VE, Lynch MP (1996) Effective treatment of anti Jo-1 antibody-positive polymyositis with cyclosporin. Br J Rheumatol 1:144-145
30. Chang HK, Lee DH (2003) Successful combination therapy of cyclosporin and methotrexate for refractory polymyositis with anti-Jo1 antibody. J Korean Med Sci 18:131-134
31. Miller FW, Leitman SF, Cronin ME, Hicks JE, Leff RL, Wesley R (1992) Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 21:1380-1384
32. Cuturic M, Hayat GR, Volger CA, Velasques A (1997) Toxoplasmic polymyositis revisited: case report and review of literature. Neuromuscul Disord 7:390-396
33. Adams EM, Hafiz GR, Carnes M, Wiesner JK, Grabiano FM (1984) The development of polymyositis in a patient with toxoplasmosis: clinical and pathologic findings and review of literature. Clin Exp Rheumatol 3:205-208
34. Yukiiri K, Mizushige K, Ueda T, Nanba T, Tanimoto K, Wada Y, Takagi Y, Ohmori K, Kohno M (2001) Fulminant myocarditis in polymyositis. Jpn Circ J11:991-993
35. Afzal A, Higgins RSD, Philbin EF (1999) Heart transplant for dilated cardiomyopathy associated with polymyositis. Heart 82:e4